September NEWSLETTER

Selected Highlighted News in the field of Autoimmune

Encephalitis September 2018 1st edition

Take part in the #StandUpforAE Challenge and help spread awareness about AE across the globe.  Researchers at Mayo Clinic, Rochester, MN have identified another antibody in AE which causes autoimmune ataxia.

Take the #StandupforAE challenge! Gab your phone and make a video stating you are standing up for Autoimmune Encephalitis and why. Post it on social media and send a copy into IAES.  Challenge others to do the same so we can raise awareness of these treatable disorders. Have FUN. Use your imagination. #StandupforAE #IAES #antiNMDAr #autoimmuneencephalitis #autoimmune #encephalitis #AEwarrior 

Mayo Clinic discovers a new antibody in Autoimmune Encephalitis

Septin-5, represents a biomarker for a potentially fatal but treatable autoimmune ataxia. This is a form of autoimmune cerebellar ataxia in which antibodies target septin-5.  All 4 patients had subacute onset of cerebellar ataxia with prominent eye movement symptoms (oscillopsia or vertigo). None had cancer detected. Improvements occurred after immunotherapies (2) or spontaneously (1). One patient died.  (Below we have included more information about ataxia as it is a symptom any AE patients suffer with. 

Cerebellar Ataxia

Ataxia describes a lack of muscle control or coordination of voluntary movements, such as walking or picking up objects. A sign of an underlying condition, ataxia can affect various movements, creating difficulties with speech, eye movement and swallowing.

Persistent ataxia usually results from damage to the part of your brain that controls muscle coordination (cerebellum).